Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
1 eventAssistance Publique - Hôpitaux de Paris — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Community
No community posts yet. Be the first to share your experience with Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Start the conversation →Latest news about Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
No recent news articles for Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
Are there clinical trials for Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum?
Yes — 1 recruiting clinical trial is currently listed for Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum?
1 specialists and care centers treating Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.